Investment Managers Series Trus (IREX)

Key Updates

IREX declined a further 3.64% since the 30 September report, moving from $13.34 to the current $12.86. This extends the uninterrupted multi-session downtrend, bringing the cumulative decline since the 25 September report to approximately 19.4% (from $15.95). The 5-day decline now stands at -24.98%, while the YTD loss has deepened to -57.66%. Two new news events were processed since the last report, both relating to leveraged ETF product launches and market infrastructure developments, but neither contains company-specific information about IREX itself. The investment thesis remains unchanged: IREX continues to exhibit severe negative momentum with no identifiable fundamental catalyst in the provided data.

Current Trend

IREX is in a pronounced downtrend. The price action shows a consistent pattern of lower closes across all recent reporting periods: $15.95 (25 Sep) → $15.46 (25 Sep intraday) → $13.90 (28 Sep) → $13.34 (1 Oct) → $12.86 (current). The 1-month return of +13.16% is now entirely offset by the 6-month decline of -25.56% and the YTD decline of -57.66%. The recent 5-day performance of -24.98% represents an acceleration of selling pressure. The price has moved from a 1-month high to a level that is now testing the lower end of its recent trading range, with no support levels identified in the provided data.

Investment Thesis

Based solely on the provided data, there is no fundamental information specific to IREX (Investment Managers Series Trust). All available news relates to leveraged and inverse ETF product launches by third-party issuers (Yorkville America, BMO/REX Shares, Leverage Shares, Tradr, Bitwise) and market infrastructure developments (Jane Street's entry into leveraged ETF swaps). These events are market-wide and do not directly reference IREX's holdings, strategy, or performance. The investment thesis must therefore be derived exclusively from price action: IREX is in a severe downtrend with -57.66% YTD performance, suggesting either a fundamentally impaired underlying portfolio or significant sector/market headwinds. Without company-specific data, the thesis is that the decline is momentum-driven and may continue until a fundamental catalyst emerges.

Thesis Status

The thesis status is unchanged from the previous report. The price continues to decline in a consistent, uninterrupted pattern. The absence of any IREX-specific news in the latest reporting period reinforces the conclusion that the selling is driven by factors not captured in the provided data. The thesis—that IREX is in a sustained bearish trend with no visible support catalyst—remains fully intact. The acceleration of the 5-day decline (-24.98%) suggests the bearish momentum is intensifying rather than abating.

Key Drivers

Based on the provided news, the following market-wide factors are relevant context, though none are IREX-specific:

• Expansion of leveraged and inverse ETF product offerings across multiple issuers, indicating growing demand for short-term tactical trading vehicles: Yorkville MNGB launch, Yorkville MNGZ launch, BMO/REX ETNs
• Anticipation of the Anthropic IPO driving pre-emptive filings for leveraged exposure: Leverage Shares filing, Tradr filing
• Increased dealer participation in leveraged ETF swaps market: Jane Street entry
• New spot crypto ETF launch: Bitwise Near ETF

Technical Analysis

IREX is trading at $12.86, down 3.64% on the day. The price action shows a clear, uninterrupted downtrend across all recent reporting periods. Key observations:

• 5-day decline: -24.98%, indicating accelerated selling pressure
• 1-month return: +13.16%, now fully offset by the 6-month decline of -25.56%
• YTD: -57.66%, representing a severe loss of value
• The price has moved from $15.95 (25 Sep) to $12.86 (current), a decline of 19.4% in approximately five trading sessions
• No support levels are identifiable from the provided data; the price appears to be in freefall with no established floor
• The consistent lower closes across all reporting periods suggest strong, sustained selling pressure with no visible buying interest

Bull Case

• 1-month return of +13.16% demonstrates that IREX is capable of significant upside moves, suggesting potential for a sharp rebound if market conditions shift (data from price movements)
• Growing market for leveraged and inverse ETFs indicates robust demand for tactical trading products, which could benefit IREX if it participates in this segment: Yorkville MNGB, Yorkville MNGZ
• Increased dealer liquidity in leveraged ETF swaps could improve market efficiency and reduce trading costs: Jane Street
• The upcoming Anthropic IPO, expected to be one of the largest AI-related offerings, could spur broader market interest and potentially lift related assets: Tradr filing
• New product innovation across the ETF landscape suggests a dynamic market environment that may present opportunities for IREX: Bitwise Near ETF

Bear Case

• YTD decline of -57.66% represents a severe, sustained loss of value with no reversal signals in the data: WSJ analysis of leveraged products
• 5-day decline of -24.98% indicates accelerating selling pressure and potential panic selling: Bloomberg on quant ETF instability
• Uninterrupted multi-session decline (at least six consecutive down sessions) suggests no buying support at current levels
• The proliferation of inverse and short ETFs provides investors with easy vehicles to profit from further declines in assets like IREX, potentially adding selling pressure: Leverage Shares short ETF, Yorkville inverse ETF
• No IREX-specific positive news or fundamental catalyst has been identified in the provided data, leaving the decline unexplained but ongoing